| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b96d359dab705c2f4497885b2399e7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dadf557e1e346f041ee781965c6ba8c2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196 |
| filingDate |
2007-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ce3d75f1b363e4978b2970132e00709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb71bd19133b3adcd1fdc3a7f424e435 |
| publicationDate |
2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007231382-A1 |
| titleOfInvention |
Pharmaceutical composition |
| abstract |
Disclosed herein are tablets and methods of treatment comprising the administration of such tablets. The tablets are immediate release tablets that comprise about 400 mg of 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof, where the 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof comprises between 60 and 70% by weight of the tablet. The methods involve the administration of the tablets of the invention to individuals in need of administration of such tablets. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9597292-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9452972-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716760-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8778991-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179118-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10945984-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9421182-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9416096-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9302977-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9682057-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135296-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9999672-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10940117-B2 |
| priorityDate |
2001-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |